GAD67: The link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis

Journal of Neural Transmission

Volumn 110, Issue 7, 2003, Pages 803-812

  Kalkman, H O ^a   Loetscher, E ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

AMPA; GABA; Glutamate decarboxylase; NMDA

Indexed keywords

4 AMINOBUTYRIC ACID; AMPA RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; ISOENZYME; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BIPOLAR DISORDER; DISEASE MARKER; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REVIEW; SCHIZOPHRENIA;

EID: 0038127153     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-003-0826-8     Document Type: Review

References (53)

1. Akbarian S, Kim J, Potkin S, Hagman J, Tafazzoli A, Bunney BJ, Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52: 258-266
2. Anand A, Charney D, Oren D, Berman R, Hu X, Cappiello A, Krystal JH (2000) Attenuation of neuropsychiatric effects of ketamine with lamotrigine. Arch Gen Psychiatry 57: 270-276
3. Anand A, Verhoeff P, Seneca N, Zoghbi S, Seibyl J, Charney D, Innes RB (2000) Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 157: 1108-1114
4. Asada H, Kawamura Y, Maruyama K, Kume H, Ding R, Ji F, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K (1996) Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem Biophys Res Commun 229: 891-895
5. Asada H, Kawamura Y, Maruyama K, Kume H, Ding R, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K (1997) Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci 94: 6496-6499
6. Bacci J, Kerkerian-Le Goff L, Salin P (2002) Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat. Eur J Neurosci 15: 1918-1928
7. Berrettini WH, Nurnberger JI, Narrow W, Simmons-Alling S, Gershon ES (1986) Cerebrospinal fluid studies in patients with and without a history of suicide. Ann NY Acad Sci 487: 197-201
8. Bertolino A, Nawroz S, Mattay V, Barnett A, Duyn J, Moonen C, Frank JA, Tedeschi G, Weinberger DR (1996) Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 153: 1554-1563
9. Bertolino A, Breier A, Callicot J, Adler C, Mattay V, Shapiro M, Frank JA, Pickar D, Weinberger DR (2000) The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacol 22: 125-132
10. Blum BP, Mann JJ (2002) The GABAergic system in schizophrenia. Int J Neuropsychopharmacol 5: 159-179
11. Callicot J, Bertolino A, Egan M, Mattay V, Langheim F, Weinberger D (2000) Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am J Psychiatry 157: 1646-1651
12. 2A receptor blockade plus L-DOPA in dopamine denervated rats. Synapse 44: 166-174
13. Costa E, Pesold C, Auta J, Caruncho H, Davis J, Davidkova G, Dwivedi Y, Grayson DR, Rodriguez MA, Uzunov D, Guidotti A (2000) Reelin and GAD67 downregulation and psychosis vulnerability. Biol Psychiatry 47: 68S
14. Danos P, Baumann B, Bernstein H, Franz M, Stauch R, Northoff G, Krell D, Falkai P, Bogerts B (1998) Schizophrenia and anteroventral thalamic nucleus: selective decrease in parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res: Neuroimaging Sect 82: 1-10
15. Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148: 1474-1486
16. Delamillieure P, Fernandez J, Constans J, Brazo P, Benali K, Abadie P, Vasse T, Thibaut F, Courteoux P, Petit M, Dollfus S (2000) Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report. Am J Psychiatry 157: 641-643
17. Ellinwood E (1976) Amphetamine psychosis I. Description of the individuals and process. J Nerv Ment Dis 144: 273-283
18. Farber N, Kim S, Dikranian K, Jiang X, Heinkel C (2002) Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol Psychiatry 7: 32-43
19. 67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry 57: 1061-1069
20. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes F (2002) Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 69: 521-529
21. Impagnatiello F, Guidotti A, Pesold C, Dwivedi Y, Caruncho H, Pisu M, Uzunov D, Smallheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E (1998) A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci 95: 15718-15723
22. Javitt D, Zukin S (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308
23. Kegeles L, Martinez D, Kochan L, Hwang D, Huang Y, Mawlawi O, Suckow RW, Van Heertum RL, Laruelle M (2002) NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans. Synapse 43: 19-29
24. Kim JS, Kornhuber HH, Schmid-Burke W, Holzmüller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379-382
25. Krystal J, Karger L, Seibyl J, Freeman G, Delaney R, Bremner J, Heninger GR, Bowers MB, Charney D (1994) Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans: psychotomimetic perception, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214
26. 65), the GABA transporter GAT-1 and GABA transaminase in rat cortex. Naunyn Schmiedebergs Arch Pharmacol 357: 32-38
27. Laprade N, Soghomonian J (1995) Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Mol Brain Res 34: 65-74
28. Laruelle M (2000) The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev 31: 371-384
29. Lewis D, Cruz D, Melchitzki D, Pierri J (2001) Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry 158: 1411-1422
30. Lindefors N (1993) Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum. Prog Neuropsychopharmacol Biol Psychiatry 17: 887-903
31. Lindefors N, Hurd Y, O'Connor W, Brené S, Persson H, Ungerstedt U (1992) Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens. Neurosci 48: 439-448
32. Lipska B, Weinberger D (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacol 23: 223-229
33. Lipska B, Jaskiw G, Weinberger D (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacol 9: 67-75
34. Loscher W, Siemes H (1985) Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Epilepsia 26: 314-319
35. Mathé J, Nomikos G, Schilstrom B, Svensson T (1998) Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J Neurosci Res 51: 583-592
36. Matthysse S (1973) Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc 32: 200-205
37. Meyer-Lindenberg A, Miletich R, Kohn P, Espositi G, Carson R, Quarantelli M, Weinberger DR, Berman KF (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nature Neurosci 5: 267-271
38. Moghaddam B, Adams B (1998) Reversal of phencyclidine effects by group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352
39. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927
40. Olney J, Labruyere J, Price M (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360-1362
41. Pierce R, Kalivas R (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25: 192-216
42. Qin Z, Zhang S, Weiss B (1994) Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Mol Brain Res 21: 293-302
43. Roberts E (1972) Prospects for research on schizophrenia: an hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosci Res Program Bull 10: 468-482
44. Sakai K, Gao X, Hashimoto T, Tamminga C (2001) Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Synapse 39: 152-160
45. Sato M, Numachi Y, Hamamura T (1992) Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schiz Bull 18: 115-122
46. 2A heteroreceptors on thalamocortical glutamatergic neurons. J Neurosci 20: 8846-8852
47. Segal D, Kuczenski R (1997) Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical charactrization. J Pharmacol Exp Ther 282: 561-573
48. Sharp J, Petersen D, Langford M (1995) DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in rat cingulate and retrospinal cortex. Brain Res 687: 114-124
49. 67 expression in various regions of rat brain. J Neurosci Res 52: 736-741
50. Soghomonian J, Martin D (1998) Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19: 500-505
51. Stelzer A, Laas R, Fleissner A (1985) Subcellular distribution of glutamic acid decarboxylase in rat brain regions following electroconvulsive stimulation. J Neural Transm 62: 99-106
52. Volk D, Austin M, Pierri J, Sampson A, Lewis D (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57: 237-245
53. Walker E, Bollini A (2002) Pubertal neurodevelopment and the emergence of psychotic symptoms. Schiz Res 54: 17-23